Feedback / Questions
OvaRex (oregovomab) - CanariaBio
https://www.prnewswire.com/news-releases/specialised-therapeutics-signs-exclusive-license-agreement-with-canariabio-for-new-ovarian-cancer-therapy-301954406.html
Oct 12, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next